Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines
Pharmaceutics · 22.03.2023 · 15 (3) · 1026
DOI: 10.3390/pharmaceutics15031026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 22.03.2023. Verfasst von Giovanni Smaldone und 6 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Synlab SDN, Via Gianturco 113, 80143 Naples, Italy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Introduction: Hydrogel nanoparticles, also known as nanogels (NGs), have been recently proposed as alternative supramolecular vehicles for the delivery of biologically relevant molecules like anticancer drugs and contrast agents. The inner compartment of peptide based NGs can be opportunely modified according to the chemical features of the cargo, thus improving its loading and release. A full understanding of the intracellular mechanism involved in nanogel uptake by cancer cells and tissues would further contribute to the potential diagnostic and clinical applications of these nanocarriers, allowing the fine tuning of their selectivity, potency, and activity. The structural characterization of nanogels were assessed by Dynamic Light Scattering (DLS) and Nanoparticles Tracking Analysis (NTA) analysis. Cells viability of Fmoc-FF nanogels was evaluated by MTT assay on six breast cancer cell lines at different incubation times (24, 48, and 72 h) and peptide concentrations (in the range 6.25 × 10−4 ÷ 5·10−3 × wt%). The cell cycle and mechanisms involved in Fmoc-FF nanogels intracellular uptake were evaluated using flow cytometry and confocal analysis, respectively. Fmoc-FF nanogels, endowed with a diameter of ~130 nm and a zeta potential of ~−20.0/−25.0 mV, enter cancer cells via caveolae, mostly those responsible for albumin uptake. The specificity of the machinery used by Fmoc-FF nanogels confers a selectivity toward cancer cell lines overexpressing the protein caveolin1 and efficiently performing caveolae-mediated endocytosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Synlab SDN, Via Gianturco 113, 80143 Naples, Italy.
- Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples "Federico II", 80131 Naples, Italy.
ORCID-Profile: Giovanni Smaldone, Enrico Gallo, Carlo Diaferia, Mariano Stornaiuolo, Antonella Accardo
Förderung
- Italian Ministry of Health
Zitieren
APA
Smaldone, G., Rosa, E., Gallo, E., Diaferia, C., Morelli, G., Stornaiuolo, M., & Accardo, A. (2023). Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines. Pharmaceutics, 15(3), 1026. https://doi.org/10.3390/pharmaceutics15031026
Vancouver
Smaldone G, Rosa E, Gallo E, Diaferia C, Morelli G, Stornaiuolo M, et al. Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines. Pharmaceutics. 2023;15(3):1026. doi:10.3390/pharmaceutics15031026
BibTeX
@article{Smaldone2023,
author = {Smaldone, Giovanni and Rosa, Elisabetta and Gallo, Enrico and Diaferia, Carlo and Morelli, Giancarlo and Stornaiuolo, Mariano and Accardo, Antonella},
title = {Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {1026},
doi = {10.3390/pharmaceutics15031026}
}
EUVIMED